[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567629":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":10,"centralContacts":38,"locations":44,"responsibleParty":76,"collaborators":10,"id":78,"slug":79,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":84,"eligibilityCriteria":85,"healthyVolunteers":86,"sex":87,"minAge":88,"maxAge":89,"enrollmentInfo":90,"targetDuration":10,"studyType":93,"phases":10,"briefSummary":94,"conditions":95,"keywords":99,"overallStatus":47,"whyStopped":10,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"Aktiia SA","INDUSTRY",[8,16,20],{"label":9,"type":10,"description":11,"interventionNames":12},"ARM 1 G1 Aktiia users Android",null,"Research participants are Aktiia G1 users with Android operating system, i.e. individuals who already purchased the Aktiia G1 device out of the context of the study, located in Switzerland, Germany or UK, and owning a smartphone with Android operating system.",[13,14,15],"Other: Lifestyle survey completion","Other: Unlimited on-demand blood pressure measurements with G2C","Other: Continual blood pressure measurements with G1",{"label":17,"type":10,"description":18,"interventionNames":19},"ARM 2 G1 AKTIIA users iOS","Research participants are Aktiia G1 users with iOS operating system, i.e. individuals who already purchased the Aktiia G1 device out of the context of the study, located in Switzerland, Germany or UK, and owning a smartphone with iOS operating system.",[13,14,15],{"label":21,"type":10,"description":22,"interventionNames":23},"ARM 3 non-Aktiia-G1-users Android & iOS","Research participants are non-Aktiia-G1 users (they do not own an Aktiia G1 device at their inclusion in the study), located in Switzerland, Germany or UK, and owning a smartphone with either iOS or Android operating system.",[13,14],[25,30,34],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":10},"OTHER","Lifestyle survey completion","For the next 10 years, starting at their inclusion in the research project and every 6 months thereafter: fill in an online survey on their lifestyle- health- socioeconomic environment. The completion of a survey lasts 5min maximum.",[9,17,21],{"type":26,"name":31,"description":32,"armGroupLabels":33,"otherNames":10},"Unlimited on-demand blood pressure measurements with G2C","For the next 10 years: take unlimited on-demand measurements with the Aktiia G2C feature (finger measurement) while seated",[9,17,21],{"type":26,"name":35,"description":36,"armGroupLabels":37,"otherNames":10},"Continual blood pressure measurements with G1","For the next 10 years: wear their 24\u002F7 Aktiia G1 device continuously as they would outside the context of the research project.",[9,17],[39],{"name":40,"role":41,"phone":42,"phoneExt":10,"email":43},"Pascale Vermare","CONTACT","+41 32 552 20 52","pascale.vermare@aktiia.com",[45,62],{"facility":46,"status":47,"city":48,"state":10,"zip":10,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Fully remote study- no physical investigational site","RECRUITING","Lausanne","Switzerland","CH",{"type":52,"coordinates":53},"Point",[54,55],6.63282,46.516,{"lat":55,"lon":54},[58],{"name":59,"role":41,"phone":60,"phoneExt":10,"email":61},"Pr Wuerzner, MD","+41 21 314 02 23","gregoire.wuerzner@chuv.ch",{"facility":46,"status":47,"city":63,"state":10,"zip":10,"country":64,"countryCode":65,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"London","United Kingdom","UK",{"type":52,"coordinates":67},[68,69],-0.12574,51.50853,{"lat":69,"lon":68},[72],{"name":73,"role":41,"phone":74,"phoneExt":10,"email":75},"Dr. Manish SAXENA, MD","0207 882 3856","m.saxena@qmul.ac.uk",{"type":77,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100567629","evaluation-of-the-clinical-benefit-of-the-aktiia-blood-pressure-monitoring-for-early-awareness-of-hypertension-and-prediction-of-cardiovascular-risk-100567629",false,"NCT06670677","Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk","OBPM_FORESEE2024: Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk in a Multi-ethnic European Population: an Observational Cohorts' Study","FORESEE2024","Inclusion Criteria:\n\n1. Adult subjects aged 21 to 85 years old\n2. Subjects living in Switzerland, Germany or in the UK\n3. Subjects that are:\n\n   Aktiia users owning a smartphone with either iOS or Android operating system (ARMs 1 and 2); or Aktiia non-users owning a smartphone with iOS or Android operating system (ARM 3)\n4. Subjects agreeing to follow the study procedures.\n\nExclusion Criteria:\n\n1. Subjects suffering from sustained cardiac arrhythmias that can lead to weak or unstable pressure pulses including resting tachycardia (heart rate at rest \\> 120bpm) and atrial fibrillation;\n2. Subjects suffering from pathologies that systematically reduce peripheral perfusion including Raynaud's disease, diabetes, renal dysfunctions (eGFR \\\u003C 30mL \u002F min \u002F 1.73 m2), untreated hyper-\u002F hypothyroidism, pheochromocytoma, or arteriovenous fistula;\n3. Subjects suffering from polyneuropathy;\n4. on pregnant women;\n5. Subjects with damaged \u002F injured skin at the wrists (for bracelet measurements) or at index fingers (for camera measurements)\n6. Subjects with amputated index fingers (for camera measurements) or amputated upper limb;\n7. Subjects below 21 years old and above 85 years old.",true,"ALL","21 Years","85 Years",{"count":91,"type":92},15000,"ESTIMATED","OBSERVATIONAL","Because Aktiia S.A. has been the first-ever company to put in the market an Optical Blood Pressure Monitoring device, there is a need for Aktiia S.A. to correlate for the first time continual Blood Pressure monitoring and the evolution of environmental and health factors to improve hypertension management.",[96,97,98],"Hypertension","Cardiovascular Risk","Blood Pressure Check (Hypertension Screening)",[100,101,102,103,104,105],"hypertension","blood pressure","Hypertensive","cardiovascular diseases","cardiovascular risk","prediction","2025-05-12",{"date":108,"type":109},"2025-05-14","ACTUAL",{"date":106,"type":109},{"date":112,"type":92},"2035-05-31",{"name":5,"class":6},2]